Invetus working with CannPal on medical cannabis for your pets

CannPal is a pet pharmaceutical Company that has identified an opportunity to benefit from the rapidly growing medical cannabis sector, by developing standardised and dosage controlled, regulatory approved pharmaceuticals, derived from the cannabis plant.

Invetus is the Clinical Research Organisation contracted by CannPal to assist with some of the registration trials - we are very practised at this type of research, although it is the first time we've worked with cannabis!

Read more about this exciting collaboration below: 

CannPal primed to test flagship cannabis pain relief drug for animals

Australian Scientists Are Developing Medical Cannabis For Your Pets